Hercules Capital (HTGC) Stock
NEW YORK STOCK EXCHANGE INC. · HTGC
17.22
Fundamentals
Market cap
$3.25B
Price / Earnings ratio
8.5x
Price / Sales ratio
5.7x
Price / Book ratio
1.4x
Return on assets
0.1%
Ex-Dividend date
11 Aug 2026
Last payment date
N/A
Dividend amount
$0.47
Dividend yield
10.5%
Debt / Equity ratio
N/A
Latest news
About Hercules Capital
Hercules Capital, Inc. is the leading and largest specialty finance company focused on providing senior secured venture growth loans to high-growth, innovative venture capital-backed companies in a broad variety of technology, life sciences and sustainable and renewable technology industries. In 2003, Hercules was founded with a vision to serve the needs of both entrepreneurs and public investors, in providing an alternative investment vehicle by which they could gain access to the prestigious and elusive world of venture capital investing.
SectorFinancial Services
IndustryAsset Management
Employees100
CEOMr. Scott Bluestein
IPO DateJun 9, 2005
HeadquartersSan Mateo, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Scott Bluestein | CEO, Chief Investment Officer & Director | 1978 |
| Mr. Seth Hardy Meyer | President | 1969 |
| Mr. Christian Follmann | Chief Operating Officer | 1983 |
| Ms. Kiersten Zaza Botelho | Chief Legal Officer, Chief Compliance Officer & Corporate Secretary | — |
| Mr. Andrew Jordan Olson C.F.A., CPA | Chief Financial Officer | 1983 |
| Mr. Michael W. Hara | Managing Director of Investor Relations & Corporate Communications | — |
| Ms. Jasmine Saadati | Director of Corporate Development | — |
| Ms. Kate Kinlin | VP of Human Resources | — |
| Mr. Roy Y. Liu | Managing Director | 1961 |
| Mr. R. Bryan Jadot | Senior MD & Group Head of Life Sciences | 1964 |
Fundamentals
Valuation
Market cap$3.25B
Price-to-sales ratio5.74
Price-to-book value1.43
Price-earnings ratio8.50
Return on Equity15.00%
Return on Sales0.79%
Return on Assets0.07%
PEG ratio0.52
Earnings Per Share
Earnings Per Share$2.08
Income Statement
Average volume1,467,975
EBITDA$438.74M
1 year high (52w)$19.46
1 year low (52w)$13.70
Dividend
Ex dividend date11 Aug 2026
Dividend amount$0.47
Dividend yield10.51%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



